FEATURESJ&J’s Oral IL-23 Peptide Icotrokinra Delivers In UC After Psoriasis Triumphadmin2 years agoMarch 20, 2025278By Anna Bratulic Johnson & Johnson's icotrokinra met the primary endpoint of a Phase IIb ulcerative colitis (UC) study, building...
